Cargando…
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis
The prolactin-inducible protein (PIP/GCPD15) is believed to originate from a limited set of tissues, including breast and salivary glands, and has been applied as a clinical marker for the diagnosis of metastatic tumours of unknown origin. We have investigated the potential role of PIP mRNA as a mar...
Autores principales: | Clark, J W, Snell, L, Shiu, R P C, Orr, F W, Maitre, N, Vary, C P H, Cole, D J, Watson, P H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362951/ https://www.ncbi.nlm.nih.gov/pubmed/10576657 http://dx.doi.org/10.1038/sj.bjc.6690799 |
Ejemplares similares
-
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro
por: Widschwendter, M, et al.
Publicado: (1999) -
Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer
por: Sauer, Natalia, et al.
Publicado: (2023) -
Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
por: Jung, R, et al.
Publicado: (1999) -
Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis
por: Urbaniak, Anna, et al.
Publicado: (2023) -
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
por: Hathaway, Cassandra A., et al.
Publicado: (2023)